Practical Management Pearls for Immunotherapy for the Treatment of Hepatocellular Carcinoma

When:  Dec 6, 2021 from 17:30 to 18:30 (ET)
18CIG-logo-rgb.jpgOn Monday, December 6, 2021 from 5:30 – 6:30 p.m. ET, join leading experts from the SITC Hepatocellular Carcinoma Immunotherapy Guideline Expert Panel for "Practical Management Pearls for Immunotherapy for the Treatment of Hepatocellular Carcinoma – SITC CPG Webinar." This high-level webinar is designed so that attendees will know how to appraise and classify organ-specific considerations for immunotherapy agents and toxicities, identify and manage clinically significant uncommon toxicities, and determine optimal sequencing of immunotherapies in relapsed and/or refractory disease.

Webinar Faculty:
  • Co-moderator: Tim F. Greten, MD – National Institutes of Health* (Expert Panel Chair)
  • Co-moderator: Lisa H. Butterfield, PhD – Parker Institute for Cancer Immunotherapy
  • Ghassan Abou-Alfa, MD, MBA – Memorial Sloan Kettering Cancer Center
  • Richard S. Finn, MD – David Geffen School of Medicine at UCLA
*Dr. Greten is serving in his personal capacity.

REGISTER NOW


The Practical Management Pearls and Case Studies Webinars are part of the Cancer Immunotherapy Clinical Practice Guidelines Advanced Webinar Series supported, in part, by grants from Amgen and Merck & Co., Inc. (as of 9/15/2021).
0c5fc50a2c9f4300afadbcc55b201f99.jpg
The SITC Clinical Practice Guidelines are produced and funded solely by SITC. No outside funding is received for the development of the manuscripts.